ARVN (Arvinas, Inc) Stock Analysis - Hedge Fund Holdings
Arvinas, Inc (ARVN) is a publicly traded Healthcare sector company. As of May 21, 2026, ARVN trades at $8.99 with a market cap of $566.50M and a P/E ratio of -1.34. ARVN moved +6.43% today. Year to date, ARVN is -18.53%; over the trailing twelve months it is +37.05%. Its 52-week range spans $5.90 to $29.61. Analyst consensus is buy with an average price target of $15.20. Rallies surfaces ARVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns ARVN stock?
Hedge funds tracked by Rallies that own ARVN include Panagora Asset and Mangrove Partners. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Arvinas, Inc.
ARVN Key Metrics
Key financial metrics for ARVN
Metric
Value
Price
$8.99
Market Cap
$566.50M
P/E Ratio
-1.34
EPS
$-6.62
Dividend Yield
0.00%
52-Week High
$29.61
52-Week Low
$5.90
Volume
717.59K
Avg Volume
0
Revenue (TTM)
$78.50M
Net Income
$-367.30M
Gross Margin
0.00%
Top Hedge Funds Holding ARVN
Panagora Asset holds 297.19K shares of ARVN, changed +13.56% as of Dec 31, 2024.
Mangrove Partners holds 69.26K shares of ARVN, changed +0.00% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own ARVN include Panagora Asset and Mangrove Partners. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Arvinas, Inc.
Does Rallies show 13F holders for ARVN?
Yes. Rallies tracks hedge fund and 13F ownership data for ARVN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ARVN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ARVN. It does not provide personalized investment advice.
